Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 15, Issue 12
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Case Reports: Findings that shed new light on the possible pathogenesis of a disease
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis
Online download statistics by month:
Online download statistics by month: December 2022 to September 2023
Abstract
Full
Pdf
Dec 2022
909
37
24
Jan 2023
496
31
26
Feb 2023
297
12
8
Mar 2023
234
6
6
Apr 2023
114
15
3
May 2023
106
11
6
Jun 2023
155
13
8
Jul 2023
120
7
3
Aug 2023
68
4
4
Sep 2023
84
4
3
Total
2583
140
91
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF